ABOUT THE SERVICE
A Phase 1/2a clinical trial testing the safety, tolerability, and preliminary efficacy of IMM01-STEM in elderly individuals with age-related muscle atrophy associated with knee osteoarthritis.
Information is owner-confirmed
Last updated 2 weeks ago
Price range
Other products/services from Immunis, Inc.
IMM01-STEM
Biotechnology
N/A
Immunis, Inc.
United States (US)